PL265
| Code | Size | Price |
|---|
| TAR-T28426-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
PL265 is a long-acting dual ENKephalinase inhibitor (DENKi) with analgesic potential.
CAS:
1206514-62-6
Formula:
C27H35N2O9P
Molecular Weight:
562.556
Purity:
0.98
SMILES:
CC(C)C(=O)OCOC(=O)N[C@@H](C)P(O)(=O)C[C@@H](Cc1ccc(cc1)-c1ccccc1)C(=O)N[C@@H](C)C(O)=O
References
1. Bonnard E, Poras H, Fourni?-Zaluski MC, Roques BP. Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain. Eur J Pharmacol. 2016 Oct 5;788:176-82. doi: 10.1016/j.ejphar.2016.05.041. Epub 2016 Jun 4. PubMed PMID: 27266667.